Table 1.
Analysis of GABAA active drugs on phase resetting
| One-way ANOVA | |||
|---|---|---|---|
| CT | F statistic | p value | |
| CT6 | (2,21) = 8.544 | *0.002 | |
| CT13.5 | (4,16) = 16.438 | *0.000 | |
| CT19 | (4,17) = 5.455 | *0.005 | |
| LSD post hoc | |||
| CT | Treatment vs | Treatment | p value |
| CT6 | SALINE-NP | MUSCIMOL-NP | *0.001 |
| THIP-NP | 0.488 | ||
| MUSCIMOL-NP | SALINE-NP | *0.001 | |
| THIP-NP | *0.004 | ||
| THIP-NP | SALINE-NP | 0.488 | |
| MUSCIMOL-NP | *0.004 | ||
| CT13.5 | SALINE-LP | MUSCIMOL-LP | *0.000 |
| THIP-LP | *0.000 | ||
| MUSCIMOL-NP | *0.000 | ||
| THIP-NP | *0.000 | ||
| MUSCIMOL-LP | SALINE-LP | *0.000 | |
| THIP-LP | *0.019 | ||
| MUSCIMOL-NP | *0.015 | ||
| THIP-NP | 0.913 | ||
| THIP-LP | SALINE-LP | *0.000 | |
| MUSCIMOL-LP | *0.019 | ||
| MUSCIMOL-NP | 0.696 | ||
| THIP-NP | 0.051 | ||
| MUSCIMOL-NP | SALINE-LP | *0.000 | |
| MUSCIMOL-LP | *0.015 | ||
| THIP-LP | 0.696 | ||
| THIP-NP | *0.036 | ||
| THIP-NP | SALINE-LP | *0.000 | |
| MUSCIMOL-LP | 0.913 | ||
| THIP-LP | 0.051 | ||
| MUSCIMOL-NP | *0.036 | ||
| CT19 | SALINE-LP | MUSCIMOL-LP | *0.003 |
| THIP-LP | *0.001 | ||
| MUSCIMOL-NP | *0.007 | ||
| THIP-NP | *0.006 | ||
| MUSCIMOL-LP | SALINE-LP | *0.003 | |
| THIP-LP | 0.541 | ||
| MUSCIMOL-NP | 0.863 | ||
| THIP-NP | 0.879 | ||
| THIP-LP | SALINE-LP | *0.001 | |
| MUSCIMOL-LP | 0.541 | ||
| MUSCIMOL-NP | 0.459 | ||
| THIP-NP | 0.694 | ||
| MUSCIMOL-NP | SALINE-LP | *0.007 | |
| MUSCIMOL-LP | 0.863 | ||
| THIP-LP | 0.459 | ||
| THIP-NP | 0.766 | ||
| THIP-NP | SALINE-LP | *0.006 | |
| MUSCIMOL-LP | 0.879 | ||
| THIP-LP | 0.694 | ||
| MUSCIMOL-NP | 0.766 |
*
p < 0.05.